Parker Drake R. 4
4 · Intersect ENT, Inc. · Filed Jul 31, 2017
Insider Transaction Report
Form 4
Parker Drake R.
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2017-07-27+50,000→ 50,000 totalExercise: $27.30Exp: 2027-07-26→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The vesting commencement date of the option is July 27, 2017. 25% of the shares subject to the option shall vest on July 27, 2018 and 1/48th of the shares subject to the option shall vest monthly thereafter over three (3) years.